Funding Rounds
AFYX Therapeutics

AFYX Therapeutics Series A (2017, $17M)

AFYX Therapeutics

Mucosal diseases treatment developer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $17.70M

Raised Date: 2017-09-01

Investors